LUND, Sweden, Feb. 15, 2018 /PRNewswire/ —
The shareholders of NeuroVive Pharmaceutical AB (publ), 556595-6538, are hereby convened to the Extraordinary General Meeting, held at 2 pm on Thursday 22 March 2018 at Medicon Village, Scheelevägen 2, in Lund, Sweden.
Entitlement to…
